Two new compounds from edible mushroom Sarcomyxa edulis

Nat Prod Res. 2023 May;37(9):1491-1497. doi: 10.1080/14786419.2021.2023146. Epub 2022 Jan 6.

Abstract

Chemical investigation of the edible mushroom Sarcomyxa edulis led to the isolation of one new highly degraded sterol (1), and one new β-carboline alkaloid (2), along with nine known compounds (3-11) for the first time from this mushroom. The structures of new compounds were elucidated using HR-ESI-MS data and NMR spectroscopy. In addition, anti-inflammatory activity of new compounds was evaluated against lipopolysaccharide-induced NO production in RAW 264.7 macrophages. Compound 2 exhibited a good anti-inflammatory activity with IC50 value of 9.88 ± 0.48 μM, and compound 1 exhibited a weak inhibitory effect with IC50 value of 71.36 ± 5.11 μM.

Keywords: Sarcomyxa edulis; anti-inflammatory activity; sterol; β-carboline alkaloid.

MeSH terms

  • Agaricales* / chemistry
  • Alkaloids* / pharmacology
  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Macrophages
  • Mice
  • Molecular Structure
  • RAW 264.7 Cells

Substances

  • Alkaloids
  • Anti-Inflammatory Agents

Supplementary concepts

  • Sarcomyxa edulis